Showing 6,721 - 6,740 results of 7,063 for search '(( significant ((changes decrease) OR (largest decrease)) ) OR ( significant step decrease ))', query time: 0.64s Refine Results
  1. 6721

    Image 3_The global burden of hypertension and its epidemiological impacts on adolescents and young adults: projections to 2050.jpeg by Chaofeng Niu (17746406)

    Published 2025
    “…</p>Results<p>From 1990 to 2021, the absolute numbers of hypertension-related deaths, Disability-Adjusted Life Years (DALYs), and Years Lived with Disability (YLDs) increased significantly globally. The age-standardized mortality rate and DALY rate decreased to some extent, while the YLDs rate increased slightly. …”
  2. 6722

    Table 3_Inequalities and age-period-cohort effects of global and regional burden for interstitial lung disease and pulmonary sarcoidosis: based on Global Burden of Disease study 20... by Lei Zhang (38117)

    Published 2025
    “…Background<p>Interstitial lung disease (ILD) and pulmonary sarcoidosis pose significant disease burdens on a global scale.</p>Methods<p>The underlying data was derived from the Global Burden of Disease (GBD) 2021 database. …”
  3. 6723

    Supplementary Material for: Non-Prescribed Use of Opioid Agonist Medications and Associations with Non-Fatal Overdoses: A Repeated Cross-Sectional Study Across a Decade of Reduced... by figshare admin karger (2628495)

    Published 2025
    “…There was no change in non-fatal overdoses in the past month (8.2% in both years), though past-year overdoses decreased (23.6% in 2013 versus 15.9% in 2023, p=0.001). …”
  4. 6724

    Table 2_Evolving landscape of female cancers along with attributable risk factors in China from 1990 to 2021, and projections to 2040.xlsx by Yali Han (4676677)

    Published 2025
    “…Background<p>Female cancers pose a significant health burden in China, and this study identified and projected epidemiological trends of these cancers.…”
  5. 6725

    Table 1_Inequalities and age-period-cohort effects of global and regional burden for interstitial lung disease and pulmonary sarcoidosis: based on Global Burden of Disease study 20... by Lei Zhang (38117)

    Published 2025
    “…Background<p>Interstitial lung disease (ILD) and pulmonary sarcoidosis pose significant disease burdens on a global scale.</p>Methods<p>The underlying data was derived from the Global Burden of Disease (GBD) 2021 database. …”
  6. 6726

    Image 5_The global burden of hypertension and its epidemiological impacts on adolescents and young adults: projections to 2050.jpeg by Chaofeng Niu (17746406)

    Published 2025
    “…</p>Results<p>From 1990 to 2021, the absolute numbers of hypertension-related deaths, Disability-Adjusted Life Years (DALYs), and Years Lived with Disability (YLDs) increased significantly globally. The age-standardized mortality rate and DALY rate decreased to some extent, while the YLDs rate increased slightly. …”
  7. 6727

    <b>Data from: </b><b>Experimentally increased food availability allows for earlier departure in a long-distance migratory shorebird</b> by Thomas Lameris (20888213)

    Published 2025
    “…We did not include start of plumage status change as more than halve of the individuals did not show plumage changes. …”
  8. 6728

    Neurochemical identity of dFB<sup>23E10</sup>Ո<sup>84C10</sup> neurons. by Joseph D. Jones (13883524)

    Published 2025
    “…A Kruskal–Wallis ANOVA followed by Dunn’s multiple comparisons revealed that acutely silencing VGlut-AD; 84C10-DBD and 84C10-AD; ChAT-DBD neurons significantly decreases sleep. ****<i>P</i> < 0.0001. …”
  9. 6729
  10. 6730
  11. 6731
  12. 6732

    Table 1_Digital health management models improve the metabolism, sleep, and gut microbiota in patients with metabolic disorders.docx by Jie Zhang (64655)

    Published 2025
    “…All outcomes in the DHM group were significantly superior to those in the control group (all p < 0.05).…”
  13. 6733
  14. 6734

    Data Sheet 1_How low can you go? Antibiotic use in Swedish dogs with gastroenteritis.pdf by Ditte Ljungquist (20446670)

    Published 2024
    “…The yearly level of antibiotic use in CGE declined from 8.1% in 2020 to 3.9% in 2023, with a statistically significant annual percentage change (APC) of −21.3% (95% CI, −22.8 to −19.7). …”
  15. 6735
  16. 6736

    Table 1_Effect of cholecalciferol on immune and vascular function in non-diabetic chronic kidney disease.docx by Kajal Kamboj (12769602)

    Published 2025
    “…A significant increase in mRNA expression of vitamin D-responsive genes (cathelicidin, IL-10, VDR, and CYP27B1) was observed. …”
  17. 6737

    Data Sheet 3_How low can you go? Antibiotic use in Swedish dogs with gastroenteritis.pdf by Ditte Ljungquist (20446670)

    Published 2024
    “…The yearly level of antibiotic use in CGE declined from 8.1% in 2020 to 3.9% in 2023, with a statistically significant annual percentage change (APC) of −21.3% (95% CI, −22.8 to −19.7). …”
  18. 6738

    Data Sheet 2_How low can you go? Antibiotic use in Swedish dogs with gastroenteritis.pdf by Ditte Ljungquist (20446670)

    Published 2024
    “…The yearly level of antibiotic use in CGE declined from 8.1% in 2020 to 3.9% in 2023, with a statistically significant annual percentage change (APC) of −21.3% (95% CI, −22.8 to −19.7). …”
  19. 6739
  20. 6740